Metabolomics Biomarkers of Neurodegeneration

Client

Corewell Health is a not-for-profit health system that provides health care and coverage with an exceptional team of 65,000+ dedicated people, including more than 12,000 physicians and advanced practice providers and more than 15,500 nurses providing care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities, and Priority Health, a provider-sponsored health plan serving more than 1.3 million members.

Background

Identify small molecules that could be used for diagnostics of various neurological conditions and neurodegenerative disorders.

Solutions

  • Targeted and untargeted mass spectrometry data processing pipeline
  • Integration of metabolomics, epigenomics and other data sources
  • AI-based predictors for diagnostics and identification of novel therapeutic targets

Publications

Scientific Reports, read full article: Link
Genes, read full article: Link

Cover image credits: Anusorn / Adobe Stock

Similar Resources

Case Study Clock Foundation
Success stories
October 27, 2026

Embedded Interpretation as a Service Differentiator

Organizations that generate omics data as a service, such as contract research organizations (CROs), build their core competency around data generation: study design, sample preparation, sequencing or mass spectrometry, and ...

bupp
Success stories
September 24, 2026

Systemic disease characterization and therapeutic optimization

Rare disease research often runs into the same wall: small, heterogeneous patient cohorts where conventional analysis struggles to separate real biological signals from noise. A research team at Corewell Health, ...